Patents Assigned to Yissum Research Development Company of the Hebrew University
  • Publication number: 20200087148
    Abstract: Provided is a composite of a CNT assembly including a plurality of carbon nanotubes (CNTs) and at least one metalcone material, the composite being tunable, by a vapor phase chemical modification, to adopt one or more collective properties selected from mechanical, chemical, physical or electrical properties.
    Type: Application
    Filed: February 21, 2018
    Publication date: March 19, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventor: Roie YERUSHALMI
  • Publication number: 20200079738
    Abstract: The present invention provides processes for the preparation of diverse heterocyclic scaffolds from alpha-enaminone building bloc of formula (I).
    Type: Application
    Filed: March 21, 2018
    Publication date: March 12, 2020
    Applicant: Yissum Research Development Company, of The Hebrew University of Jerusalem Ltd.
    Inventor: Dmitry TSVELIKHOVSKY
  • Patent number: 10584157
    Abstract: Disclosed are peptides comprising amino acid residues of the dimer interface of human B7-1 and B7-2 and compositions and uses thereof.
    Type: Grant
    Filed: March 16, 2016
    Date of Patent: March 10, 2020
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
    Inventors: Raymond Kaempfer, Revital Levy
  • Publication number: 20200075034
    Abstract: A method and system for enhancing a speech signal is provided herein. The method may include the following steps: obtaining an original video, wherein the original video includes a sequence of original input images showing a face of at least one human speaker, and an original soundtrack synchronized with said sequence of images; and processing, using a computer processor, the original video, to yield an enhanced speech signal of said at least one human speaker, by detecting sounds that are acoustically unrelated to the speech of the at least one human speaker, based on visual data derived from the sequence of original input images.
    Type: Application
    Filed: November 11, 2019
    Publication date: March 5, 2020
    Applicant: Yissum Research Development Company of The Hebrew University of Jerusalem LTD.
    Inventors: Shmuel PELEG, Asaph SHAMIR, Tavi HALPERIN, Aviv GABBAY, Ariel EPHRAT
  • Patent number: 10568834
    Abstract: Provided is a novel dilutable delivery systems and propofol microemulsions suitable for intravenous delivery of propofol.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: February 25, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Nissim Garti, Sharon Garti Levi, Abraham Aserin, My Perlstein
  • Patent number: 10570174
    Abstract: Synthetic peptides containing chemical modifications having anti-tumor properties are provided. Further provided are pharmaceutical compositions including the peptides and use thereof for treating proliferative and neoplastic diseases such as cancer.
    Type: Grant
    Filed: February 7, 2016
    Date of Patent: February 25, 2020
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventor: Uri Wormser
  • Publication number: 20200048233
    Abstract: The invention provides efficient cyclization processes of hydroxyalkenoic acids and products produced therefrom. The following reactions are claimed: Formula (I), (II), (V) and (VI).
    Type: Application
    Filed: February 14, 2018
    Publication date: February 13, 2020
    Applicant: Yissum Research Development Company, of The Hebrew University of Jerusalem Ltd.
    Inventor: Dmitry TSVELIKHOVSKY
  • Publication number: 20200048252
    Abstract: A method of preventing or treating a disease characterized by an excessive immune response in a subject in need thereof is provided. The method includes administering to the subject a composition including an active component, wherein the active component is a first compound, a second compound, a third compound, a pharmaceutically acceptable salt thereof, a solvate thereof, or a combination thereof, wherein the first, second, and third compounds include: respectively.
    Type: Application
    Filed: October 21, 2019
    Publication date: February 13, 2020
    Applicants: FRAUNHOFER-GESELLSCHAFT ZUR FĂ–RDERUNG DER ANGEWANDTEN FORSCHUNG E.V., YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD.
    Inventors: Anke BURGER-KENTISCHER, Angela MATTES, Maria ZATSEPIN, Amriam GOLDBLUM
  • Publication number: 20200031714
    Abstract: Provided are objects constructed of compressed salt combinations including salt and at least one additive, wherein the at least one additive is selected to impart the object with resistance to water and humidity.
    Type: Application
    Filed: March 27, 2018
    Publication date: January 30, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Daniel MANDLER, Noa LAPIDOT, Andrea BUFFA, Gabriel DIKOVSKY, Lihi RIKANATI
  • Patent number: 10541970
    Abstract: A method and system for providing Deep Packet Inspection (DPI) as a service to a computer network are provided herein. The contribution of embodiments of the present invention is two-folded. First, a possible framework of having DPI deployed as a service is detailed, including the necessary algorithms and required adaptations. Second, the superior performance of the suggested design is demonstrated via simulations. Since the focus is on the algorithmic aspects and network design, an SDN implementation of the suggested design is not provided herein. However, many aspects of such an SDN implementation follow closely the guidelines known in the art.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: January 21, 2020
    Assignee: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
    Inventors: David Hay, Yaron Koral, Yotam Harchol, Anat Brembler-Barr
  • Patent number: 10534007
    Abstract: The present invention provides a method for the assay of synucleins in a body fluid or tissue sample, wherein said method comprises the steps of contacting said sample with membrane lipids under conditions enabling binding of the synuclein to said lipids, and the detection of the lipid-bound synuclein by a synuclein-binding agent.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: January 14, 2020
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
    Inventor: Ronit Sharon
  • Publication number: 20200009067
    Abstract: Provided is a formulation and method for increasing bioavailability of an orally administered drug.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 9, 2020
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Amnon HOFFMAN, Abraham J. DOMB, Anna ELGART, Irina CHERNIAKOV
  • Publication number: 20200000934
    Abstract: Provided is an antiangiogenic agent in the form of a vehicle, e.g., a nanoparticle associated (directly or indirectly) with at least one ocular angiogenesis growth factor aptamer, wherein said association labile to interaction between the aptamer and an ocular angiogenesis growth factor.
    Type: Application
    Filed: February 28, 2018
    Publication date: January 2, 2020
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Bar Ilan University
    Inventors: Itamar WILLNER, Sharon ETERY, Yossi MANDEL, Amos MARKUS, Asaf SHOVAL
  • Publication number: 20190390077
    Abstract: Provided is a novel photoinitiator in the form of a hybrid nanoparticle constructed of a semiconductor and metallic regions, and uses thereof.
    Type: Application
    Filed: August 27, 2019
    Publication date: December 26, 2019
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Uri BANIN, Hermona SOREQ, Shlomo MAGDASSI, Nir WAISKOPF, Yuval BEN-SHAHAR, Amol ASHOK PAWAR, Shira HALIVNI
  • Publication number: 20190388679
    Abstract: A method of analyzing performance of a brain stimulation tool is disclosed. The method comprises: obtaining encephalography data collected from a brain of a subject electrically stimulated by at least one of the electrode contacts of the brain stimulation tool; segmenting the data into a plurality of epochs, each corresponding to a single stimulation event generated by the brain stimulation tool; and applying a spatiotemporal analysis to the epochs so as to determine at least one of (i) location of the at least one electrode contact in the brain, and (ii) therapeutic effect of the at least one electrode contact.
    Type: Application
    Filed: March 7, 2018
    Publication date: December 26, 2019
    Applicants: Elminda Ltd., Yissum Research Development Company of the Hebrew University of Jersusalem Ltd.
    Inventors: Amir B. GEVA, Hagai BERGMAN, Ziv PEREMEN, Dror HAOR, Daniel SAND, Yaki STERN, Boaz SADEH
  • Publication number: 20190367940
    Abstract: Disclosed herein are genetically modified plants having altered biological activity of 3-?-hydroxysteroid dehydrogenase/isomerase (GAME25), or 2-oxoglutarate-dependent dioxygenase (GAME31), or a combination thereof, wherein the genetically modified plants have an altered content of at least one cholesterol derived compound selected from the group including a steroidal alkaloid or a glycosylated derivative thereof and an unsaturated or saturated steroidal saponin or a glycoside derivative thereof. Further disclosed herein are genetically modified plants having altered expression of a gene encoding a 3-?-hydroxysteroid dehydrogenase/isomerase (GAME25), or a 2-oxoglutarate-dependent dioxygenase (GAME31), or a combination thereof, wherein the genetically modified plant has an altered content of at least one cholesterol derived compound selected from the group including a steroidal alkaloid or a glycosylated derivative thereof and an unsaturated or saturated steroidal saponin or a glycoside derivative thereof.
    Type: Application
    Filed: February 8, 2018
    Publication date: December 5, 2019
    Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD., Yissum Research Development Company, of The Hebrew University of Jerusalem Ltd.
    Inventors: Asaph AHARONI, Prashant SONAWANE, Pablo D. CARDENAS, BURDMAN Saul
  • Patent number: 10493123
    Abstract: Disclosed are methods for treating, preventing and alleviating obesity, fatty liver syndrome, diabetes, one or more metabolic syndrome conditions or complications and/or cancer comprising administering an effective amount of ostreolysin, its functionally related variant, or an extract or mushroom extract comprising the same to subjects in need thereof.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: December 3, 2019
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF of The Hebrew University of Jerusalem LTD.
    Inventors: Betty Schwartz, Einav Yehuda-Shnaidman, Lili Nimri
  • Patent number: 10475465
    Abstract: A method and system for enhancing a speech signal is provided herein. The method may include the following steps: obtaining an original video, wherein the original video includes a sequence of original input images showing a face of at least one human speaker, and an original soundtrack synchronized with said sequence of images; and processing, using a computer processor, the original video, to yield an enhanced speech signal of said at least one human speaker, by detecting sounds that are acoustically unrelated to the speech of the at least one human speaker, based on visual data derived from the sequence of original input images.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: November 12, 2019
    Assignee: Yissum Research Development Company, of The Hebrew University of Jerusalem Ltd.
    Inventors: Shmuel Peleg, Asaph Shamir, Tavi Halperin, Aviv Gabbay, Ariel Ephrat
  • Patent number: 10466422
    Abstract: An optical device includes a first waveguide having a longitudinal axis and a first end facet inclined at a non-normal angle to the longitudinal axis, and a second waveguide, which has a second end facet and is fixed with the second end facet in proximity to and parallel with the first end facet. An actuator is coupled to move the first end facet of the first waveguide in a direction transverse to the longitudinal axis between a first position in which a distance between the first and second end facets is less than 25 nm, and a second position in which the distance between the first and second end facets is greater than 300 nm.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: November 5, 2019
    Assignees: Mellanox Technologies, Ltd., Yissum Research Development Company of the Hebrew University LTD.
    Inventors: Eran Aharon, Dan Mark Marom, Elad Mentovich
  • Publication number: 20190330138
    Abstract: The present invention provides compounds comprising fused tricyclic backbone structure and processes for their preparation. The invention further provides compounds and compositions useful in the treatment of pain and any type of disorder or symptom associated therewith.
    Type: Application
    Filed: June 17, 2019
    Publication date: October 31, 2019
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Dmitry TSVELIKHOVSKY, Avi PRIEL